CLINICAL PHARMACOKINETICS CONCEPTS IN THE DRUG DISCOVERY AND DEVELOPMENT PROCESS OF PHYTOMEDICINES IN SOME DEVELOPING COUNTRIES

Journal Title: World Journal of Pharmaceutical and life sciences - Year 2018, Vol 4, Issue 7

Abstract

Clinical Pharmacokinetics can be defined as the study of the relationship between drug dosage regimens and the concentration time profiles. There has been in the last decades a significant progress in the field of Clinical Pharmacokinetics (CPK) in the drug development process and the understanding of the ethical and regulatory demands within the pharmaceutical industries. The three basic parameters that govern PK relationships are Clearance i.e. the volume of the blood that is cleared out completely of the drug per unit time, Distribution volume i.e. the apparent volume in which the drug has been distributed to make the measured concentration and half-life i.e. the time that is required for 50 percent of the drug to be completely eradicated. The knowledge of clearance can be useful in calculating the dose rate needed to retain a target concentration. In addition, elimination half-time helps in determining the time needed for a drug to be completely eliminated from the body. It also indicates the time taken to attain a steady state and can be further used to determine the optimum dosage interval for producing the target peak to trough. On similar lines, essential advancement has been made in the rational design of quinine dosage regimens for patients in places such as Africa and South East Asia. This review paper attempts to discuss ethical issues in clinical Pharmacokinetics in the development of new drugs for poverty related diseases in developing economies. The paper attempts to give an overview of the effect of pharmacokinetics as a factor on therapeutic failure, and how PK can support therapeutic drug monitoring in a clinical setting and its relevance in herbal medicines research. The ethical issues involving PK studies have been discussed.

Authors and Affiliations

Tembe Fokunang E. A.

Keywords

Related Articles

DIVERSITY OF PLANT SPECIES ALONG WITH INVASIVE ALIEN SPECIES OF SHOREA ROBUSTA GAERTN AND PINUS RO XBURGHII SARG (350-1900 M) FORESTS OF NAINITAL DISTRICT WEST HIMALAYA

Biological invasions are often thought to be one of the leading threats to global biodiversity. Plant invaders of natural ecosystems, also termed ‘environmental weeds’, have been shown to inhibit the recruitment of resid...

EFFECT OF A POLY-PILL OF METFORMIN, ARTESUNATE AND ESOMEPRAZOLE LOW-DOSE (MEALD) COMBINATION IN PREVENTION OF MALARIA AND SELECTED METABOLIC SYNDROME CRITERIA

Malaria-induced attenuation of the insulin signalling pathway may be important in the aetiology of T2DM, while T2DM has been linked with increased malaria risk. AMPK activators, of which metformin, artesunate and esomepr...

CLINICAL AND ELECTROPHYSIOLOGICAL EVALUATION OF BELL'S PALSY CASES IN RESPONSE TO TREATMENT

Background: Bell’s palsy is an abrupt, isolated, unilateral, peripheral facial paralysis without detectable cause. It is the most common cause of unilateral facial weakness. Patients and methods: The study was carried ou...

ORGANOLEPTIC CHARACTERS, PHYSIOCHEMICAL AND PRELIMINARY PHYTOCHEMICAL ANALYSIS OF THRIKADUGU, PARANGIPATTAI AND MASIKKAI CHOORANAM

AIM: The aim of the study is to evaluate Organoleptic characters, Physiochemical parameters and to screen the phytochemicals present in three Siddha formulations – Thrikaduku chooranam (TKC), Parangipattai chooranam (PPC...

ROLE OF VAMANA KARMA AND NIMBADI CHURNA WITH PATOLADI KWATHA AS ANUPANA IN THE MANAGEMENT OF EKA KUSHTA W. S. R. PLAQUE PSORIASIS - A REVIEW ARTICLE

In today‟s world everyone sees what you appear to be. Appearance is nothing but the skin. Skin diseases are affecting the mankind since time immortal. Skin is a mirror that reflects external and internal pathology, and i...

Download PDF file
  • EP ID EP655806
  • DOI -
  • Views 147
  • Downloads 0

How To Cite

Tembe Fokunang E. A. (2018). CLINICAL PHARMACOKINETICS CONCEPTS IN THE DRUG DISCOVERY AND DEVELOPMENT PROCESS OF PHYTOMEDICINES IN SOME DEVELOPING COUNTRIES. World Journal of Pharmaceutical and life sciences, 4(7), 22-32. https://europub.co.uk/articles/-A-655806